Most AI drug development firms are focused on discovery. AI biotech Formation Bio is betting the real bottleneck is clinical trials. With a new $600 million fund to buy or license potential drugs that have stalled out, the startup now hopes to prove th…
This week’s Current Climate newsletter also looks at a new push to restore federal funds for electric buses and Corning’s CEO on solar business and carbon capture tech.
A flight recorder for wayward AI systems. The space industry’s record investments. AI spending warnings. All that and more in this week’s Prototype.
Researchers Regrew Knee Cartilage In Mice. Now A Biotech Is Doing Clinical Trials.
This week’s Current Climate newsletter also looks at using infrastructure investment to tackle climate change and Chargepoint CEO Rick Wilmer on U.S. market changes.
A flight recorder for wayward AI systems. The space industry’s record investments. AI spending warnings. All that and more in this week’s Prototype.
In this week’s edition of InnovationRx, the bumper crop of biotech IPOs, Isomorphic’s reported $40 billion valuation fundraise, and the impact of drugmakers’ gifts to doctors.
The threat of quantum computers to government systems, how AI is upending math and the ongoing Pentagon-Anthropic saga. All that and more in this week’s Prototype.
This week’s Current Climate also looks at how Trump’s war with Iran is helping used EV sales and the compelling economic case for the clean energy transition.
In this week’s edition of InnovationRx, we look at Cleveland Clinic’s AI for brain seizures, Fidji Simo’s plan to solve complex, chronic disease, and Vivek Ramaswamy’s estimated $12 million tax cut.